Quanta Announces Dosing of First Patient in Phase 1/1b Clinical Trial of QTX3046
27 Jun 2024 //
GLOBENEWSWIRE
Quanta Presents Preclinical Data for QTX3544 at AACR
08 Apr 2024 //
GLOBENEWSWIRE
Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544
05 Mar 2024 //
GLOBENEWSWIRE
Quanta Announces IND Clearance by U.S. FDA for QTX3034
04 Jan 2024 //
GLOBENEWSWIRE
Quanta Therapeutics Presents Late-Breaking Data for QTX3034
11 Oct 2023 //
GLOBENEWSWIRE
Quanta Therapeutics bags $50M for two 2024 clinical trials
22 May 2023 //
ENDPTS
Quanta Therapeutics Raises Over $50 Million in Series D Financing
22 May 2023 //
GLOBENEWSWIRE
Quanta Therapeutics Presents Data from KRAS Inhibitor Pipeline at Annual AACR
14 Apr 2023 //
GLOBENEWSWIRE
Quanta Announces Two Presentations from KRAS Inhibitor Pipeline
14 Mar 2023 //
GLOBENEWSWIRE
Quanta Therapeutics Appoints Leonardo Faoro, MD, as Chief Medical Officer
13 Dec 2022 //
GLOBENEWSWIRE